Wednesday, February 10, 2010, 8:31am EST - Canadian Markets open in 59 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Glaxosmithkline plc (GSK)

 On Feb 9: 38.47 USD   0.00 (0.00%)  
MORE ON GSK
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
GLAXOSMITHKLINE PLC (NYSE:GSK) Delayed quote dataEdit
Pre-Market: 37.69 Down 0.20 (0.53%) as of 8:09am EST on 02/10/10
Last Trade: 38.47 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 37.89
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 56.10
Day's Range: N/A - N/A
52wk Range: 27.15 - 43.47
Volume: 1,100
Avg Vol (3m): 1,788,550
Market Cap: 97.52B
P/E (ttm): 10.18
EPS (ttm): 3.78
Div & Yield: 1.855 (4.90%)
Glaxosmithkline plc (GSK)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add GSK to Portfolio   Download Data

HEADLINES
• Bone Up On This Potential Blockbuster
at Motley Fool (Tue 11:58am)
• Europe Launches Probe into Pharma Deals
at BusinessWeek (Tue 10:52am)
• Germany Cancels Swine Flu Vaccines
at BusinessWeek (Tue 10:52am)
• Glaxo considering job cuts at UK research center
AP (Tue 10:41am)
• Biotech Deal-Making Crosses Borders as Capital Markets Slide
at Seeking Alpha (Tue 4:32am)
• Dynavax starts hepatitis B trial
at bizjournals.com (Mon, Feb 8)
• Popular antidepressant interferes with cancer drug
at Reuters (Mon, Feb 8)
• UPDATE - Roche licenses new flu-fighting technology
at Reuters (Mon, Feb 8)
• GlaxoSmithKline, Poniard, Protalix Provide Biotech's Latest Mishaps
at Seeking Alpha (Mon, Feb 8)
• How Big Pharma Got in This Fix
at Seeking Alpha (Sun, Feb 7)
• Believe In The Market's Healthy Skepticism
at Forbes.com (Fri, Feb 5)
• Big Pharma's Shot In The Arm
at CNBC (Fri, Feb 5)
• Vaccines Drive Glaxo's Revenues
Zacks.com (Fri, Feb 5)
• Business Highlights
AP (Thu, Feb 4)
More Headlines for GSK...
ANALYST
EPS Est (next year) (Dec-07) : 3.86
EPS Est (in 2 years) (Dec-08) : 3.96
Avg Rec (current)*: 2.9
PEG Ratio: 2.65
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical and consumer health-related products.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices